NU SKIN ENTERPRISES, INC. Cash and Restricted Cash
NU SKIN ENTERPRISES, INC. (NUS) had Cash and Restricted Cash of $189.64 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-10
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $189.64M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $198.65M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $238.63M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $251.79M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $189.64M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $198.65M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $238.63M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $251.79M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $264.16M 10-Q · filed 2026-08-10 |
| 2025-03-31 | $203.77M 10-Q · filed 2026-05-08 |
| 2024-12-31 | $186.88M 10-Q · filed 2026-08-10 |
| 2024-09-30 | $227.75M 10-Q · filed 2025-11-07 |
| 2024-06-30 | $224.25M 10-Q · filed 2025-08-08 |
| 2024-03-31 | $212.53M 10-Q · filed 2025-05-09 |
| 2023-12-31 | $256.06M 10-K · filed 2026-02-13 |
| 2023-09-30 | $233.31M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $235.55M 10-Q · filed 2024-08-09 |
| 2023-03-31 | $229.94M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $264.73M 10-K · filed 2026-02-13 |
| 2022-09-30 | $294.14M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $363.92M 10-Q · filed 2023-08-02 |
| 2022-03-31 | $302.22M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $339.59M 10-K · filed 2025-02-14 |
| 2021-09-30 | $282.41M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $354.76M 10-Q · filed 2022-08-05 |
| 2021-03-31 | $339.10M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $402.68M 10-K · filed 2024-02-15 |
| 2020-09-30 | $366.71M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $375.51M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $352.58M 10-Q · filed 2021-05-05 |
| 2019-12-31 | $335.63M 10-K · filed 2023-02-16 |
| 2019-09-30 | $320.03M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $360.63M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $310.29M 10-Q · filed 2020-05-07 |
| 2018-12-31 | $386.91M 10-K · filed 2022-02-16 |
| 2018-09-30 | $390.07M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $402.03M 10-Q · filed 2019-08-07 |
| 2017-12-31 | $426.40M 10-K · filed 2021-02-11 |
| 2016-12-31 | $357.25M 10-K · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |